Webinar: Navigating Communication on Clinical Trials in Oncology скачать в хорошем качестве

Webinar: Navigating Communication on Clinical Trials in Oncology

Clinical trials are the cornerstone of advancing cancer treatment, offering patients cutting-edge therapies while contributing to critical research. However, effective communication between patients and oncologists is essential to ensure understanding, participation, and optimal outcomes. In Cancer Nation’s 2024 State of Survivorship Survey, participation in clinical trials remains consistent, with key drivers being the doctor’s recommendation (51%) and the prospect of access to new treatments (28%). Among patients who did not participate in clinical trials, 74% of patients said that they were not asked, which remains the largest barrier. Patients also cited concerns about side effects, treatment protocols, and location as secondary barriers, with these concerns being more prominent among younger patients and patients of color. This webinar discusses the role of communication in clinical trial participation. Viewers will gain insight into how communication can influence trial participation, improve patient understanding, and address concerns such as eligibility, side effects, and informed consent. Viewers will also learn about resources related to clinical trial participation available to oncology professionals and their patients. Featured speakers for this presentation: Kristi Mitchell, MPH of Health Equity Outcomes Don S. Dizon, MD of Tufts University Joseph Unger, PhD of Fred Hutch Cancer Center See the slides, speaker bios and more on our blog: Check out our 2024 State of Survivorship Survey Findings: https://canceradvocacy.org/survey2024/ This webinar is presented by Cancer Nation (formerly the National Coalition for Cancer Survivorship). This webinar is sponsored by Lilly. 00:00 Survivorship Survey Clinical Trial Data 05:02 Kristi Mitchell--Community Engagement 10:15 Don Dizon--How Co-Op Groups Help Participation 19:20 Joseph Unger--Structural Barriers 26:21 How do we address structural barriers? 39:22 Language and Timing to Engage Patients 53:01 Financial Barriers and Issues